Adult ADHD Prescribing

​​​Request 837526379​

1. Any current written policies, guidance, or protocols (from January 2023 to present) relating to the prescribing of medication for Attention Deficit Hyperactivity Disorder (ADHD) for adults.

2. Any documents or recorded information (including reports, meeting minutes, or internal communications) from January 2023 to present that record or discuss decisions to reduce, restrict, pause, or stop ADHD prescribing, and the reasons for those decisions.

3. Any risk assessments, clinical safety considerations, or impact assessments relating to changes in ADHD prescribing practice for adults during this period.​

Response 

1
Health and Care Jersey (HCJ) does not currently have any specific policies, guidance or protocols relating to the prescribing of medication for ADHD in adults, though a policy is under development in 2026.

In the absence of HCJ policy, the National Institute for Health and Clinical Excellence (NICE) guidelines are observed. Find the NICE ADHD management guidance at National Institute for Health and Care Excellence (NICE) guideline NG87: Attention deficit hyperactivity disorder: diagnosis and management​.​​

2

Records held by Health and Care Jersey have been reviewed for documents and communications in scope of the request. An update on ADHD medicines shortages and prescribing was issued in February 2024, ADHD update February 2024​.

No meeting minutes or correspondence has been identified which meet the request criteria.

3
No such information has been identified by HCJ's Adult ADHD Service.​